We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

221 hedge funds and large institutions have $674M invested in Ironwood Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 77 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

92,654% more call options, than puts

Call options by funds: $46.4M | Put options by funds: $50K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 226 → 221 (-5)

5.47% less ownership

Funds ownership: 107.8% → 102.34% (-5.5%)

10% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 77

11% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 44

40% less capital invested

Capital invested by funds: $1.12B → $674M (-$443M)

Holders
221
Holders Change
-5
Holders Change %
-2.21%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
39
Increased
69
Reduced
77
Closed
44
Calls
$46.4M
Puts
$50K
Net Calls
+$46.3M
Net Calls Change
-$27.1M

Top Buyers

1
Pacer Advisors
Pacer Advisors
Pennsylvania
+$12.8M
2
KCM
Kynam Capital Management
New Jersey
+$11M
3
SCM
Stonepine Capital Management
Oregon
+$5.12M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.23M
5
State Street
State Street
Massachusetts
+$3.64M

Top Sellers

1
BCM
Brown Capital Management
Maryland
-$16.8M
2
Man Group
Man Group
United Kingdom
-$11.2M
3
GT
Glenmede Trust
Pennsylvania
-$9.1M
4
JP Morgan Chase
JP Morgan Chase
New York
-$8.31M
5
First Eagle Investment Management
First Eagle Investment Management
New York
-$7.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
VI
76
Vestcor Inc
New Brunswick, Canada
$657K +$235K +43,703 +38%
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
$637K +$391K +72,815 +89%
Prudential Financial
78
Prudential Financial
New Jersey
$621K -$16.9K -3,150 -2%
Comerica Bank
79
Comerica Bank
Texas
$619K +$575K +106,892 +247%
Canada Life
80
Canada Life
Manitoba, Canada
$611K -$172K -32,053 -18%
California State Teachers Retirement System (CalSTRS)
81
California State Teachers Retirement System (CalSTRS)
California
$557K -$14K -2,598 -2%
DFCM
82
Dark Forest Capital Management
Puerto Rico
$529K +$366K +68,028 +113%
Connor, Clark & Lunn Investment Management (CC&L)
83
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$520K +$408K +75,917 +151%
AA
84
ALPS Advisors
Colorado
$484K -$34.6K -6,440 -5%
SL
85
Siren LLC
Connecticut
$455K +$594K +110,532 New
Thrivent Financial for Lutherans
86
Thrivent Financial for Lutherans
Minnesota
$455K -$30.8K -5,734 -5%
Ohio Public Employees Retirement System (OPERS)
87
Ohio Public Employees Retirement System (OPERS)
Ohio
$453K +$4.37K +812 +0.7%
GCM
88
Graham Capital Management
Connecticut
$445K +$580K +107,970 New
T. Rowe Price Associates
89
T. Rowe Price Associates
Maryland
$426K +$10.3K +1,908 +2%
KCM
90
Kennedy Capital Management
Missouri
$422K -$7.2K -1,339 -1%
CM
91
Cercano Management
Washington
$418K +$545K +101,378 New
II
92
Inspire Investing
Idaho
$416K +$249K +46,352 +85%
GC
93
Guggenheim Capital
Illinois
$413K +$55.4K +10,307 +11%
Massachusetts Financial Services
94
Massachusetts Financial Services
Massachusetts
$410K -$13K -2,409 -2%
Mirae Asset Global ETFs Holdings
95
Mirae Asset Global ETFs Holdings
Hong Kong
$383K +$47.5K +8,829 +10%
CC
96
Clearline Capital
New York
$383K – – –
Ensign Peak Advisors
97
Ensign Peak Advisors
Utah
$352K – – –
PA
98
Profund Advisors
Maryland
$339K +$37.6K +6,986 +9%
Susquehanna International Group
99
Susquehanna International Group
Pennsylvania
$336K +$48.6K +9,047 +12%
CF
100
Corebridge Financial
Texas
$334K -$4.45K -827 -1%
2 3
4
5 6

IRWD Hedge Fund Activity: Q3 2024 in Review

221 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2024, worth a combined $674M — down 40% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IRWD and 39 opened new positions — a net loss of 5 holders — while 77 trimmed existing stakes and 69 added.

The largest buyer was Pacer Advisors, adding an estimated $12.8M. The largest seller was Brown Capital Management, exiting entirely with an estimated $16.8M sold.

  • 221 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2024, down from 226 in Q2 2024.
  • Funds reported $674M of Ironwood Pharmaceuticals stock for Q3 2024, down 40% quarter-over-quarter.
  • 39 funds opened new Ironwood Pharmaceuticals positions in Q3 2024 and 44 closed out, a net change of -5 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2024 was Pacer Advisors, an estimated $12.8M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2024 was Brown Capital Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q3 2024.